In June 2023, DSM-Firmenich successfully placed shares by way of an accelerated bookbuilding raising gross proceeds of approx. EUR 733 million. The proceeds will be used for the buy-out of shares not tendered in the exchange offer to DSM shareholders. Goldman Sachs, ABN AMRO and J.P. Morgan acted as joint global coordinators in this transaction.